P2.16-02 Pembrolizumab, Lenvatinib and Chemotherapy Combination in First Line Extensive-Stage Small Cell Lung Cancer: PEERS Phase 2 Trial
N. Reguart Aransay,I. Victoria,J. L. Marti,E. Carcereny,H. Arasanz,M. Domine,N. Fernandez,M. A. Sala,E. Marin,E. Sanfeliu,A. Arcocha,D. Martinez,R. Reyes,A. Navarro,A. Barba,R. Garcia-Campelo, J. Giner,A. Blasco,E. Sais,V. Gutierrez,R. Marse, P. Martin, J. Zugazagoita,B. Salinas, S. Cobo,M. Provencio Journal of thoracic oncology（2023）
关键词
ES-SCLC,Lenvatinib,Pembrolizumab
AI 理解论文
溯源树
样例
